Are Pharmaceuticals and Biotech Emerging as New Market Leaders? How to Maximize the Opportunity
The pharmaceutical and biotech sectors, which had been left behind in the semiconductor-driven market, have recently shown strong performance. The healthcare index has significantly outperformed the semiconductor index, attracting substantial foreign buying. Eased U.S. tariff risks and news of global new drug and technology transfers are boosting domestic investor sentiment.
Securities firms predict that this trend will continue through the first half of next year. Global trends such as obesity and metabolic disease treatments, along with domestic companies' technology exports and new drug approval achievements, are having a positive impact, leading to the analysis that there is ample room for further gains. Experts advise, "It is effective to devise a bio investment strategy alongside semiconductor and high-dividend stocks to match the rotational market expected through the end of the year."
[Link to the No.1 industry leader HisStockLoan: https://www.hisl.co.kr/5113]
Meanwhile, interest in stock-backed loans (stock loans) continues to rise. Investors who do not want to miss out on rare investment opportunities are turning to stock loans, which allow them to utilize more funds for stock purchases.
Additionally, even if investors using margin or credit experience a sharp drop in stock prices and face a forced sale crisis, one of the advantages of stock loans is that they can easily switch without providing additional collateral or selling holdings, and simply wait for a rebound.
◆ HisStockLoan: Additional investment funds at the industry's lowest annual interest rate in the 4% range, plus refinancing of margin and credit loans!
HisStockLoan has launched a securities-linked credit product that anyone can use comfortably, offering the industry's lowest annual interest rate in the 4% range. It can be used for both stock purchases and refinancing of securities firm margin/credit loans, and up to four times the investor's own capital can be utilized regardless of credit rating.
In addition, for investors who previously had difficulty using stock loans due to DSR (Debt Service Ratio) limits, a product is now available that can be used regardless of DSR. Investors using the alternative trading system (NXT) can also take advantage of these services.
Investors who want to learn more about the various customized products offered by HisStockLoan can contact the customer service center (☎1566-5113) at any time, 24 hours a day, for convenient consultation with a professional advisor, regardless of loan eligibility.
○ Launch of products with the industry's lowest annual interest rate in the 4% range
○ Products available regardless of DSR
○ No.1 market share for 21 consecutive years, winner of the Korea First Brand Award for 16 consecutive years
○ Real-time repayment of securities firm margin/credit loans
○ Trading available on the alternative trading system (NXT)
○ Reliable consultation quality guarantee system
* HisStockLoan Customer Service Center: 1566-5113
Go to: https://www.hisl.co.kr/5113
Green Optics, The Pinkfong Company, U2Bio, Jaeyoung Solutec, Mirae Nanotech
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
※ The above content is unrelated to the editorial direction of The Asia Business Daily, and all responsibility lies with the information provider.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.